Femtech, technology and software addressing women’s biological needs, has seen venture capital funding triple from $600 million in 2015 to $1.9 billion in 2021 as early stage investors have an increased interest in tech companies focused on women’s health conditions. Here are key points highlighting market growth:
- Firms focused on gynecology, fertility and maternity have garnered the largest funding.
- Femtech funding is being driven by the growth in large employers adopting services focused on maternal and family health.
- The vast majority of femtech firms are led by women.
Despite the increase in venture fund investments, analysts say the overall investment in women’s health still remains underfunded.
